Trilac IBS contains a unique combination of 10 billion CFU of microencapsulated freeze-dried lactic acid bacteria Bifidobacterium longum W11, freeze-dried lactic acid bacteria Lactobacillus rhamnosus GG (ATCC 53103) and the prebiotic component - fructooligosaccharides Actilight 950P. Trilac IBS is a probiotic with the patented DRcapsTM technology in the form of delayed-release capsules, soluble in the intestines. DRcapsTM capsules ensure that the strains safely reach the intestines. Short-chain fructo-oligosaccharides - Actilight950P are not broken down by human digestive enzymes and reach the intestines where they are a valuable medium for Bifidobacterium longum W11 and Lactobacillus rhamnosus GG (ATCC 53103).
The product is intended for children and adults with irritable bowel syndrome with chronic constipation or diarrhea, abdominal pain, flatulence, belching and gas associated with IBS **. Treatment of excessive growth of the bacterial flora of the small intestine (SIBO ***). Disorders of the digestive tract, antibiotic therapy, during and after rifaximin treatment.
1 capsule a day; best consumed with plenty of liquid 0.5 to 1 hour before or after a meal
1 capsule contains:
fructooligosaccharides, hydroxypropyl methylcellulose, lyophilisate of bacteria Bifidobacterium longum W11, lyophilisate of bacteria Lactobacillus rhamnosus SP1, thickener: gellan gum, anti-caking agent: magnesium salts of fatty acids, anti-caking agent: silicon dioxide, dye:
Do not use in case of hypersensitivity to any component of the preparation.
The preparation cannot be used as the only source of food.
It should be taken under medical supervision.
Do not exceed recommended servings for consumption during the day.
It is not suitable as the sole source of food.
The product is not intended for parenteral use.
Store in a dry place at a temperature of up to 25 degrees Celsius.